| 发明名称 |
Combination drug |
| 摘要 |
The present invention provides a pharmaceutical agent containing an HER2 inhibitor and a hormonal therapeutic agent or anti-cancer agent in combination. The present invention provides a pharmaceutical agent containing (1) an HER2 inhibitor having a pyrrolopyrimidine skeleton or pyrazolopyrimidine skeleton, and (2) a hormonal therapeutic agent or an anti-cancer agent in combination.
|
| 申请公布号 |
EP2359825(A2) |
申请公布日期 |
2011.08.24 |
| 申请号 |
EP20110156096 |
申请日期 |
2007.10.05 |
| 申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
OHTA, YOSHIKAZU;TAMURA, TOSHIYA;TAKAGI, SHINJI |
| 分类号 |
A61K31/337;A61K31/395;A61K31/4745;A61K31/505;A61K31/517;A61K31/519;A61P35/00;A61K31/5377;A61K31/565;A61K31/704 |
主分类号 |
A61K31/337 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
